“…The use of ketamine, a known NMDA antagonist and GABA A potentiator, likely modulated the baseline probability of neuronal activation and entrainment (Alkire, Hudetz, & Tononi, 2008; McGirr, LeDue, Chan, Xie, & Murphy, 2017; Michelson & Kozai, 2018). Future studies should be conducted in awake preparations, taking particular care to consider the large influence on neuronal damage, microglial activation, and astroglia scarring, which are suggested to modulate both recording and stimulation (Alba, Du, Catt, Kozai, & Cui, 2015; Kozai, Alba, et al, 2014; Wellman, Li, Yaxiaer, McNamara, & Kozai, 2019). Additionally, there is a need to directly evaluate how stimulation‐induced activity changes over time in a chronic setting given the dynamic tissue responses to implantable electrodes and its effect on the excitatory‐inhibitory balance.…”